NCT03321526: A reported trial by Janssen Research & Development, LLC
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03321526 |
|---|---|
| Title | A 6-Month, Multicenter, Double-Blind, Randomized, Flexible-Dose, Parallel-Group Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Subjects With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Dec. 12, 2017 |
| Completion date | June 13, 2019 |
| Required reporting date | June 13, 2022, midnight |
| Actual reporting date | June 9, 2022 |
| Date last checked at ClinicalTrials.gov | Aug. 26, 2025 |
| Days late | None |